Chargement en cours...
Efficacy, Tolerability, and Safety of DFN‐15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study
OBJECTIVE: The objective of this study was to evaluate the efficacy, tolerability, and safety of 120 mg DFN‐15 vs placebo for the acute treatment of migraine. BACKGROUND: Certain nonsteroidal anti‐inflammatory drugs (NSAIDs) are guideline‐recommended therapies for the acute treatment of migraine, bu...
Enregistré dans:
| Publié dans: | Headache |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7003821/ https://ncbi.nlm.nih.gov/pubmed/31647577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.13663 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|